Moderna announced Monday that their COVID-19 vaccine candidate is showing 94.5% efficacy; KDKA's Amy Wadas reports.
Managing Vaccine Expectations
KIMT
The news about two covid-19 vaccines has been absolutely remarkable
Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials
Credit: KDKA CBS 2 Pittsburgh
Duration: 00:40s
0 shares
1 views
You might like
Related news coverage
Health Headlines - 11-20-20
FOX 47 News Michigan
Reporter Update: Local Doctor Takes Part In Moderna Vaccine Trials
KDKA CBS 2 Pittsburgh
Moderna says its COVID-19 vaccine candidate is 94.5% effective
NBC 26 Wisconsin
Advertisement
More coverage
Second COVID vaccine shows promise
A COVID-19 vaccine candidate being produced by biotech company Moderna has shown to be 94.5% effective in Phase 3 clinical trials,..
FOX 4 Now Florida